drugset / Trial / NCT02779608
The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites
NaSingle-groupOpen-labelTreatment
Summary
This is a clinical Study to evaluate the effect, survival benefit and safety of intraperitoneal docetaxel combined with oral S-1 for advanced gastric cancer with malignant ascites.
Timeline
- Start
- 2017-01-20
- Primary completion
- 2018-06
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 60 mg/m2 | Other |
| Subject | S-1 | Small molecule | 40 mg/m2 | Oral |